Graham focuses his practice on representing private equity sponsors and strategic buyers in the structuring and negotiation of investments and divestitures in a broad range of industries. He also advises on corporate governance and other general corporate matters.
During law school, Graham served as an article editor for the Review of Banking and Financial Law. Graham also advised MIT and Boston University startups on seed-stage financings and general corporate matters as part of Boston University's Entrepreneurship & Intellectual Property Clinic.
- Represented Advent International and Mediq B.V. in the $380 million sale of Byram Healthcare to Owens & Minor.
- Represented Advent International in its $1.1 billion acquisition of Olaplex, a leading brand of professional haircare products.
- Represented Summit Partners in its $2.2 billion acquisition of Sound Physicians, a leading provider of hospitalist, intensivist, emergency medicine, telehealth and physician advisor services.
- Represented Summit Partners and its portfolio company, Paradigm Outcomes, in the acquisition of Adva-Net, a leading ancillary network for high-acuity workers’ compensation claims.
- Represented Access Information Management, a Berkshire Partners portfolio company, in its acquisition of Arkive Information Management.
- Represented Berkshire Partners and its portfolio company Affordable Care, Inc., in the acquisition by Affordable Care of DDS Dentures + Implant Solutions, a dental practice management company.
- Represented Bain Capital Ventures and its portfolio company, defi Solutions, in its merger with Sagent Auto.
- Represents one of the world's largest asset managers in domestic and international equity co-investments.
- Represents Baillie Gifford Overseas Limited in various venture and growth capital investments in the U.S. and overseas.
- Represents Pfizer Inc. in ongoing corporate governance, securities law compliance and reporting, and commercial law matters.
- Represented Milacron Holdings Corp., a CCMP portfolio company, in a number of secondary offerings.
- Regularly represents, on a pro bono basis, The Nature Conservancy in structuring and implementing a variety of conservation financing projects.
- Author, Recent Development, “Misbehaving Bankers: Desperate Analysts, FINRA Fines and the Toys’R’Us IPO,” 34 REV. BANKING & FIN. L. 416 (2015)
- Note, “Much Ado About Nothing: Why the Equity Crowdfunding Exemption Will Only Be Useful to a Few, and What To Do About It,” 35 REV. BANKING & FIN. L. 335 (2015)
- JD, cum laude, Boston University School of Law, 2016; Edward F. Hennessey Distinguished Scholar; article editor, Review of Banking and Financial Law
- BA (International Relations), magna cum laude, Tufts University, 2010